Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Carroll

Showing results (1121-1130 of 1,434) with videos related to

Pageof 144
Sort By:
Urology|March 12, 1998
Oral bropirimine immunotherapy of bladder carcinoma in situ after prior intravesical bacille Calmette-GuérinM F Sarosdy, M J Manyak, A I Sagalowsky, et al.
Neoplasia (New York, N.Y.)|January 16, 2007
Genomic profiling of hormone-naïve lymph node metastases in patients with prostate cancerPamela L Paris, Matthias D Hofer, Giancarlo Albo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
EBUS-TBNA for the clarification of PET positive intra-thoracic lymph nodes-an international multi-centre experienceRobert C Rintoul, Kurt G Tournoy, Hesham El Daly, et al.
Magnetic Resonance in Medicine|May 11, 2006
Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopyMark G Swanson, Andrew S Zektzer, Z Laura Tabatabai, et al.
European Urology Oncology|July 6, 2025
The Natural History of Confirmed Grade Group 1 Prostate Cancer Managed with Active Surveillance in the Modern EraKevin Shee, Jonathan J Song, Janet E Cowan, et al.
Bioconjugate Chemistry|March 1, 1997
Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTcJ A Barrett, A C Crocker, D J Damphousse, et al.
Radiology|November 1, 2001
Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled studyU G Mueller-Lisse, D B Vigneron, H Hricak, et al.
The Prostate|December 1, 2016
Tissue Sources for Accurate Measurement of Germline DNA Genotypes in Prostate Cancer Patients Treated With Radical ProstatectomyNima C Emami, Lancelote Leong, Eunice Wan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2017
Impact of <sup>68</sup>Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate CancerThomas A Hope, Rahul Aggarwal, Bryant Chee, et al.
Bioorganic & Medicinal Chemistry|February 27, 2009
(-)-Dibromophakellin: an alpha2B adrenoceptor agonist isolated from the Australian marine sponge, Acanthella costataRohan A Davis, Gregory A Fechner, Melissa Sykes, et al.
Pageof 144

Showing results (1121-1130 of 1,434) with videos related to

Sort By:
Pageof 144
Urology|March 12, 1998
Oral bropirimine immunotherapy of bladder carcinoma in situ after prior intravesical bacille Calmette-GuérinM F Sarosdy, M J Manyak, A I Sagalowsky, et al.
Neoplasia (New York, N.Y.)|January 16, 2007
Genomic profiling of hormone-naïve lymph node metastases in patients with prostate cancerPamela L Paris, Matthias D Hofer, Giancarlo Albo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
EBUS-TBNA for the clarification of PET positive intra-thoracic lymph nodes-an international multi-centre experienceRobert C Rintoul, Kurt G Tournoy, Hesham El Daly, et al.
Magnetic Resonance in Medicine|May 11, 2006
Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopyMark G Swanson, Andrew S Zektzer, Z Laura Tabatabai, et al.
European Urology Oncology|July 6, 2025
The Natural History of Confirmed Grade Group 1 Prostate Cancer Managed with Active Surveillance in the Modern EraKevin Shee, Jonathan J Song, Janet E Cowan, et al.
Bioconjugate Chemistry|March 1, 1997
Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTcJ A Barrett, A C Crocker, D J Damphousse, et al.
Radiology|November 1, 2001
Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled studyU G Mueller-Lisse, D B Vigneron, H Hricak, et al.
The Prostate|December 1, 2016
Tissue Sources for Accurate Measurement of Germline DNA Genotypes in Prostate Cancer Patients Treated With Radical ProstatectomyNima C Emami, Lancelote Leong, Eunice Wan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2017
Impact of <sup>68</sup>Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate CancerThomas A Hope, Rahul Aggarwal, Bryant Chee, et al.
Bioorganic & Medicinal Chemistry|February 27, 2009
(-)-Dibromophakellin: an alpha2B adrenoceptor agonist isolated from the Australian marine sponge, Acanthella costataRohan A Davis, Gregory A Fechner, Melissa Sykes, et al.
Pageof 144